Clinical and molecular characterization of Rubinstein‐Taybi syndrome patients carrying distinct novel mutations of the EP300 gene

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0004|87|2|148-154

ISSN： 0009-9163

Source： CLINICAL GENETICS, Vol.87, Iss.2, 2015-02, pp. : 148-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction

By Hallam T.   Bourtchouladze R.  

Cellular and Molecular Life Sciences CMLS, Vol. 63, Iss. 15, 2006-08 ,pp. : 1725-1735

Springer Publishing Company

Access to resources Recommend Favorite

Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients

By  

CLINICAL GENETICS, Vol. 9-9163, Iss. 5, 2015-11 ,pp. : 431-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients

By  

CLINICAL GENETICS, Vol. 88, Iss. 5, 2015-11 ,pp. : 431-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith–Wiedemann Syndrome: Clinical Spectrum and Functional Characterization

By  

HUMAN MUTATION, Vol. 36, Iss. 9, 2015-09 ,pp. : 894-902

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel KDM6A (UTX) mutations and a clinical and molecular review of the X‐linked Kabuki syndrome (KS2)

By  

CLINICAL GENETICS, Vol. 87, Iss. 3, 2015-03 ,pp. : 252-258

John Wiley & Sons Inc

Access to resources Recommend Favorite